• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human cGMP-inhibited 3′,5′-cyclic phosphodiesterase A (PDE3A), Truncated

ACP06215

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP06215 Target NamePDE3A
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Protein LengthPartialPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ14432
Background Information
  • Uniprot Id

    Q14432

  • Target Species

    Human

  • Target Name

    PDE3A

  • Target Full Name

    cGMP-inhibited 3',5'-cyclic phosphodiesterase 3A

  • Target Function

    Cyclic nucleotide phosphodiesterase with a dual-specificity for the second messengers cAMP and cGMP, which are key regulators of many important physiological processes.

  • Target Involvement

    Hypertension and brachydactyly syndrome (HTNB)

  • Target Subcellular Location

    Membrane; Multi-pass membrane protein.

  • Target Protein Families

    Cyclic nucleotide phosphodiesterase family, PDE3 subfamily

  • Target Synonyms

    5''-cyclic phosphodiesterase A; cAMP phosphodiesterase myocardial cGMP inhibited; CGI PDE ; CGI PDE A; CGI-PDE A; cGMP inhibited 3' 5' cyclic phosphodiesterase A; cGMP-inhibited 3''; Cyclic GMP inhibited phosphodiesterase A; Cyclic GMP-inhibited phosphodiesterase A; Human cGMP inhibited cAMP phosphodiesterase mRNA; PDE 3A; Pde3a; PDE3A_HUMAN; Phosphodiesterase 3A; Phosphodiesterase 3A cGMP inhibited

Inquire Recombinant Human cGMP-inhibited 3′,5′-cyclic phosphodiesterase A (PDE3A), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification